Kestra Medical Technologies | Seattle UX Researcher
Kestra Medical Technologies, Inc. on LinkedIn: Kestra set out from the beginning to design the ASSURE wearable…
Kestra Medical Technologies Company Profile: Funding & Investors | PitchBook
Kestra Medical Technologies Surpasses 100 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System | Business Wire
For Patients – Recover with Confidence - Kestra Medical Technologies
Kestra Medical Technologies Surpasses 100 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System | Business Wire
The Wearable Cardioverter Defibrillator: A Life (Vest) of Controversy - American College of Cardiology
Kestra Medical Technologies, Inc. - This week we will be covering the question: what is a WCD? A Wearable Cardioverter Defibrillator (WCDs) can offer support and protection during cardiac recovery. They are
Kestra Medical Technologies Nabs FDA Premarket Approval for Wearable Cardioverter Defibrillator | 24x7
SUMMARY OF SAFETY AND EFFECTIVENESS DATA (SSED)
Kestra Medical Technologies, Inc. on LinkedIn: Kestra Medical Technologies
Kestra Medical Technologies
Kestra Medical Technologies - Overview, News & Competitors | ZoomInfo.com
ASSURE Wearable Cardioverter Defibrillator (WCD) System Earns 2022 Medical Design Excellence Award | Business Wire
For more than a decade, Cardiac Insight in Bellevue has used cutting-edge technology to monitor heart health in serious athletes
ASSURE Wearable Cardioverter Defibrillator (WCD) System Earns 2022 Medical Design Excellence Award | Business Wire
ASSURE Wearable Cardioverter Defibrillator System Kit (P/N 80014-001), Monitor (P/N 80008-003), Therapy Cable (P/N 80004-003), Garment Style A (P/N 80015-XXX*) and Style B (P/N 80016-XXX*), Rechargeable Battery (P/N 3322882-005), Carry Pack (3326503-003),
A wearable cardioverter defibrillator with a low false alarm rate - Poole - 2022 - Journal of Cardiovascular Electrophysiology - Wiley Online Library
ASSURE Wearable Cardioverter Defibrillator (WCD) System Earns 2022 Medical Design Excellence Award | Business Wire
ASSURE Wearable Cardioverter Defibrillator (WCD) System Earns 2022 Medical Design Excellence Award | Business Wire
For Providers - Modern Wearable Cardiac Protection - Kestra Medical Technologies
Kestra Medical Technologies (@KestraMedical) / Twitter
Assure (wearable defibrillator)
Kestra Medical Technologies on Twitter: "The recent ACE-DETECT study shows the ASSURE system has significantly lower false‐positive shock alarm rates (one every 1,333 days) compared with the performance criteria set for the
FDA approves Kestra's ASSURE wearable cardioverter defibrillator
